-
Mashup Score: 2
Listen to this episode from Trials and Tribulations | Oncology Trials Podcast on Spotify. In Episode 4, featuring Professor Silke Gillessen, we explore the STAMPEDE trial’s Metformin comparison, discussing its rationale and predicted outcomes. We also tap into challenges with access to routine data and clinical trial regulation.
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Trials Tribs 32s FULL.mp4 - 11 day(s) ago
Shared with Dropbox
Source: www.dropbox.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
Dra. Barbara Melão entrevista o Dr. Nick James, oncologista no The Royal Master Hospital e professor do The Institute of Cancer Research, em Londres
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18
Listen to this episode from Trials and Tribulations | Oncology Trials Podcast on Spotify. In episode 2, we discuss the challenges that clinical trials face in accessing routinely collected data.
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23
Listen to this episode from Trials and Tribulations | Oncology Trials Podcast on Spotify. In episode 1, we discuss the STAMPEDE2 trial site set-up, ethics and MHRA issues.
Source: open.spotify.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 216th Bladder Cancer Translational Research Meeting - 3 month(s) ago
The Bladder Cancer Research Centre (University of Birmingham) and the Translational Oncology & Urology Research (TOUR) team (King’s College London and Guy’s Hospital) are organising their 5th Bladder Cancer Translational Research Meeting – a fully interactive bladder cancer clinical research meeting led by an international expert panel of clinicians and scientists in the U.K. The forum is designed to bridge the gap between science and clinical practice and will cover the spectrum of bladder cancer research in oncology, urology, nursing, epidemiology, immuno- and molecular biology.
Source: www.kcl.ac.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36The Lancet Commission on Prostate Cancer: preparing for the forthcoming global surge in cases | London Global Cancer Week - 6 month(s) ago
Register Now The Lancet Commission on Prostate Cancer: preparing for the forthcoming global surge in cases Hosted by: Centre for Global OncologyTue 14th November @ 12:30 pm – 2:00 pm GMT Prostate cancer is already the commonest male cancer in 112/185 countries and accounts for 15% of all male cancers. Due to projected demographic changes worldwide, coupled to rising life expectancy, cases will…
Source: www.lgcw.org.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 75How to Compose Platform Trials - 6 month(s) ago
Platform trials are adaptive randomised controlled trials that address multiple questions using a single protocol, which reduces the time taken to rea…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6Selenium and Vitamin E for Non–Muscle-Invasive Bladder Cancer - 7 month(s) ago
This randomized clinical trial assesses the ability of selenium and vitamin E to prevent non–muscle-invasive bladder cancer (NMIBC) recurrence and progression in patients with newly diagnosed disease.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Clinical Research Fellow in Urological Cancer - STAMPEDE2 trial Arm P- ( ID 628) in Chelsea (London) | The Institute of Cancer Research - 12 month(s) ago
View details and apply for this Clinical Research Fellow in Urological Cancer – STAMPEDE2 trial Arm P- ( ID 628) vacancy in Chelsea (London). Salary : Future progression is based on annual performance review. This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If…
Source: The Institute of Cancer ResearchCategories: Hem/Oncs, Latest HeadlinesTweet
https://t.co/QdRoaBkAWs